Skip to main content

Adolescent Residential Addiction Facilities Largely Do Not Provide Buprenorphine

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, June 14, 2023 -- Only one in four U.S. facilities offer buprenorphine for adolescent residential addiction treatment, according to a research letter published in the June 13 issue of the Journal of the American Medical Association.

Caroline King, Ph.D., M.P.H., from Oregon Health & Science University School of Medicine in Portland, and colleagues surveyed U.S. adolescent residential addiction treatment facilities (using a secret shopper approach) to assess treatments used for adolescents younger than 18 years seeking opioid use disorder treatment.

The researchers found that 45.2 percent of U.S. facilities provided residential treatment to patients younger than 18 years, of which 24.4 percent offered buprenorphine. Twelve facilities (7.5 percent) offered buprenorphine initiation but discontinued before discharge, 17 facilities (10.6 percent) initiated buprenorphine and offered ongoing treatment, and four facilities (2.5 percent) offered long-acting injectable buprenorphine. Most facilities treating youth (87.5 percent) had someone available who could prescribe medications for psychiatric comorbidities (e.g., depression). More than half of youth-treating facilities included family members in adolescent treatment (53.8 percent), but no other evidence-based treatment was used by more than one-third of facilities contacted.

"The average parent would need to call nine facilities on the Substance Abuse and Mental Health Services Administration Treatment Locator list to find one that offered buprenorphine and 29 to find one for an adolescent younger than 16 years," the authors write.

Several authors disclosed ties to industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Slight Decline Seen in U.S. Drug Overdose Deaths

THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...

American Psychiatric Association, May 4-8

The annual meeting of the American Psychiatric Association was held from May 4 to 8 in New York City, drawing participants from around the world, including clinicians...

Number, Size of Seizures of Fentanyl Increasing in the United States

MONDAY, May 13, 2024 -- The number and size of seizures of fentanyl are increasing in the United States, with most seizures occurring in the West, according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.